Transcriptomics is the study of an entire set of RNA transcripts produced by the genome of any organism. An increase in advancements in the field of transcriptomics such as extensive use of RNA-sequencing and a rise in the application of transcriptomics, which includes drug discovery is expected to drive the growth of the transcriptomics market. In addition, the rise in funding and grants by various private and government organizations have further stimulated the market growth. However, certain drawbacks of RNA sequencing and lack of skilled professionals are expected to restrain market growth.
The report presents an in-depth assessment of the Global Transcriptomics Industry including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Global Transcriptomics investments from 2020 till 2025.
Click the link to get a free Sample Copy of the Report:
Top Leading Manufactures-
Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, F. Hoffmann-La Roche AG, Fluidigm Corporation, Illumina Inc., Merck & Co., Inc., Promega Corporation, Qiagen NV, Thermo Fisher Scientific
Majority of the Transcriptomics products being developed by established players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness.
Pharmaceutical is applying transcriptomics to new fields and is also encouraging others to enter the field. Thermo Fisher Scientific, Inc., initiated new Ion Torrent Transcriptome Profiling Grant Program, which focusses on the benefits of gene-level expression analysis as novel biomarkers, which can help in cancer diagnostics, prognostics, and experimental therapy use.
Key Market Trends
Application of Transcriptomics in Diagnostics and Disease Profiling is Expected to Grow in the forecast period
Cancer is a dreadful disease whose prevalence has been increasing in recent times. According to the National Institute of Health, the number of new cancer cases worldwide was 14.1 million in 2012. This increased to 18.1 million new cases in 2018, according to the World Health Organization and is expected to rise to 23.6 million by 2030.
Transcriptomics has a variety of applications in diagnostics and disease analysis. Transcriptome analyses have been extensively used to understand the heterogeneity of tumors, classifying tumors into molecular subtypes and establishing signatures that predict response to therapy and patient outcomes. Massively-parallel single-cell RNA sequence analysis has emerged as a powerful method to understand the heterogeneity and to study cancers rare cell populations, through unsupervised sampling and modeling of transcriptional states in single cells.
North America dominates the market
Most global manufacturers of transcriptomic systems, platforms, equipment, and technologies are active in North America, especially in the U.S. For instance, in April 2017, NuGEN Technologies, Inc. launched two new products, Universal Plus mRNA-Seq and Trio RNA-Seq kits that allows RNA sequencing with greater efficiency from routine samples.
Inquire for Discount:
What are the market factors that are explained in the report?
–Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a Global and regional scale.
–Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.
–Analytical Tools: Global Transcriptomics Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, feasibility study, and investment return analysis have been used to analyzed the growth of the key players operating in the market.
The research includes historic data from 2014 to 2020 and forecasts until 2025 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.
Media Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
email@example.com | firstname.lastname@example.org